V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300008222 | 300004339 | 1.63 | 58.1 | Disease modification (D) | 2014-02-14 | 2014-03-06 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300015490 | CAP + RT |
| 300008223 | 300004360 | null | 83.6 | Palliative (P) | 2019-01-17 | 2019-01-27 | Oxaliplatin + Modified de Gramont | N | N | 300015592 | OXALIPLATIN + MDG |
| 300008224 | 300006817 | null | null | Palliative (P) | 2015-09-10 | 2015-10-15 | CETUXIMAB | null | N | 300015731 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300008225 | 300004387 | null | null | Curative (C) | 2016-10-14 | 2016-12-13 | Carboplatin AUC 6 - 10 | null | Y | 300015821 | CETUXIMAB |
| 300008226 | 300004394 | 1.56 | 68.4 | Palliative (P) | 2016-06-05 | 2016-06-13 | Gemcitabine + Capecitabine | 2 | N | 300015852 | NIVOLUMAB |
| 300008227 | 300004407 | 1.73 | null | Palliative (P) | 2017-08-20 | 2017-08-20 | Oxaliplatin + Modified de Gramont | 02 | null | 300015921 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300008228 | 300004453 | 1.78 | 65 | null | 2014-01-13 | 2018-02-21 | CAPECITABINE + OXALIPLATIN | 02 | Y | 300016167 | CETUXIMAB + RT |
| 300008229 | 300004473 | 1.66 | 77 | Palliative (P) | null | 2018-12-06 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | Y | N | 300016224 | CAPECITABINE |
| 300008230 | 300004482 | 1.43 | 57.7 | Adjuvant (A) | 2017-08-25 | 2017-09-03 | Oxaliplatin + Modified de Gramont | N | null | 300016288 | TRIAL |
| 300008231 | 300004492 | 1.65 | 70.25 | Palliative (P) | null | 2015-06-03 | Oxaliplatin + Modified de Gramont | 01 | N | 300016352 | CAPECITABINE + OXALIPLATIN |
| 300008232 | 300006865 | 1.63 | null | Palliative (P) | 2015-09-12 | 2018-07-05 | ESPAC-4 TRIAL | 02 | null | 300016364 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300008233 | 300004506 | 1.58 | 61.7 | Curative (C) | 2017-10-11 | 2017-10-12 | Cisplatin 7 day | 02 | null | 300016413 | CISPLATIN |
| 300008234 | 300004512 | null | 71.4 | Palliative (P) | 2014-02-12 | 2014-02-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300016451 | CETUXIMAB + RT |
| 300008235 | 300004552 | 1.55 | 65.1 | null | 2013-10-29 | 2014-09-25 | PACLITAXEL | null | null | 300016644 | TRIAL |
| 300008236 | 300004560 | null | null | Palliative (P) | 2017-11-09 | 2018-02-02 | CISPLATIN + FLUOROURACIL | Y | null | 300016735 | CISPLATIN |
| 300008237 | 300007761 | 1.69 | 71.4 | Palliative (P) | null | 2017-04-07 | CompARE Trial | Y | N | 300016805 | DOCETAXEL |
| 300008238 | 300004581 | 1.81 | 0 | Palliative (P) | 2017-08-14 | 2017-10-27 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 300016814 | CAPECITABINE + OXALIPLATIN |
| 300008239 | 300004602 | 1.58 | null | Palliative (P) | 2015-11-27 | 2016-08-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | 300016941 | OXALIPLATIN + MDG |
| 300008240 | 300004607 | null | 75.3 | Palliative (P) | 2015-09-13 | 2015-09-23 | Carboplatin AUC 6 - 10 | N | Y | 300016978 | CARBOPLATIN |
| 300008241 | 300004629 | 1.68 | 56.8 | Palliative (P) | 2017-11-11 | 2017-11-30 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300017093 | IRINOTECAN + MDG |
| 300008242 | 300004638 | null | 78 | Palliative (P) | 2017-07-18 | 2017-07-28 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 300017106 | CISPLATIN |
| 300008243 | 300004641 | 1.78 | 78.1 | Palliative (P) | null | 2016-05-02 | Docetaxel 100mg/m2 (21 day) | 02 | N | 300017110 | CARBOPLATIN + RT |
| 300008244 | 300004648 | null | 61.4 | Disease modification (D) | 2016-09-30 | 2017-04-02 | CETUXIMAB | N | N | 300017151 | CAPECITABINE |
| 300008245 | 300008120 | 1.55 | 56.1 | Curative (C) | 2014-07-16 | 2014-07-31 | CARBOPLATIN + RT | N | Y | 300017300 | CETUXIMAB + CISPLATIN + FU |
| 300008246 | 300008122 | 1.67 | 45.7 | Palliative (P) | 2016-12-27 | 2016-12-29 | NIVOLUMAB | N | N | 300017327 | CARBO + FLUOROURACIL |
| 300008247 | 300007777 | 1.58 | 69 | Curative (C) | 2015-03-21 | 2015-03-22 | CARBOPLATIN + RT | N | Y | 300017380 | CISPLATIN + FLUOROURACIL |
| 300008248 | 300004697 | 1.82 | null | Palliative (P) | 2015-01-03 | 2015-01-03 | Carboplatin AUC 2 - 5 | 02 | N | 300017468 | PEMBROLIZUMAB |
| 300008249 | 300004753 | 1.84 | null | Palliative (P) | 2018-05-02 | 2018-05-04 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 300017826 | CISPLATIN + FLUOROURACIL |
| 300008250 | 300004765 | 1.6 | 58 | Neo-adjuvant (N) | null | 2017-03-19 | Carboplatin AUC 2 - 5 | 2 | N | 300017888 | OXALIPLATIN + MDG |
| 300008251 | 300004767 | 1.73 | null | Palliative (P) | null | 2018-02-23 | CISPLATIN + FLUOROURACIL | N | N | 300017894 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 300008252 | 300004780 | 1.72 | null | Curative (C) | null | 2016-03-04 | Hydroxycarbamide | 02 | null | 300017947 | CISPLATIN |
| 300008253 | 300004783 | null | 59.4 | Curative (C) | 2017-07-27 | 2017-08-30 | Capecitabine | 02 | N | 300017954 | IRINOTECAN + MDG |
| 300008254 | 300004828 | 1.6 | 84.3 | Palliative (P) | 2015-03-19 | 2015-03-24 | Carboplatin + Etoposide iv&po | N | N | 300022505 | CAPE + CARBOPLATIN + CETUXIMAB |
| 300008256 | 300004839 | 1.61 | 60 | Palliative (P) | null | 2017-12-23 | Trial Unspecified | N | null | 300022645 | CARBOPLATIN |
| 300008257 | 300004848 | 1.63 | null | Not known (9) | 2018-02-15 | 2018-03-11 | CARBOPLATIN | N | N | 300022711 | TRASTUZUMAB |
| 300008259 | 300004867 | 1.6 | 80 | Palliative (P) | 2018-09-15 | 2018-09-15 | Methotrexate High Dose (3g/m2) | Y | N | 300022967 | CAPECITABINE + OXALIPLATIN |
| 300008260 | 300007019 | 1.77 | null | Curative (C) | 2016-03-22 | 2016-10-01 | Cetuximab 7 day (>Cycle 2) | 1 | Y | 300023002 | CISPLATIN |
| 300008261 | 300007024 | 1.79 | 73.4 | Curative (C) | 2015-04-04 | 2015-04-04 | Cisplatin 7 day | Y | Y | 300023187 | CARBOPLATIN |
| 300008262 | 300004888 | 1.49 | 54 | Palliative (P) | 2015-06-11 | 2015-06-26 | Trial Unspecified | Y | null | 300023270 | TRIAL |
| 300008263 | 300004903 | null | 83.6 | Curative (C) | null | 2017-08-21 | Cetuximab + Radiotherapy Load | null | null | 300023483 | CISPLATIN + FLUOROURACIL |
| 300008264 | 300004919 | 1.46 | 55 | Palliative (P) | 2016-08-22 | 2016-09-21 | Capecitabine | N | N | 300023703 | UKALL XII |
| 300008265 | 300004927 | 0 | 91.65 | Curative (C) | 2018-03-02 | 2018-06-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300023894 | CARBOPLATIN |
| 300008266 | 300004937 | 1.74 | 73.8 | Palliative (P) | 2013-12-17 | 2014-05-16 | Temozolomide 200mg/m2 | null | N | 300023964 | NOT MATCHED |
| 300008267 | 300007059 | 1.77 | 65.9 | Curative (C) | 2014-05-27 | 2014-06-10 | Cisplatin | 2 | Y | 300024331 | CISPLATIN + FLUOROURACIL + RT |
| 300008268 | 300004965 | 1.62 | null | Palliative (P) | 2018-06-12 | 2018-07-08 | CETUXIMAB | 2 | null | 300024361 | HYDROXYCARBAMIDE |
| 300008269 | 300004998 | 1.62 | 84.7 | Palliative (P) | null | 2016-05-07 | Cetuximab 7 day (>Cycle 2) | Y | null | 300024858 | OXALIPLATIN + MDG |
| 300008270 | 300007080 | null | null | Adjuvant (A) | 2018-05-13 | 2018-06-30 | Folfirinox | N | null | 300024921 | CARBOPLATIN + PACLITAXEL |
| 300008271 | 300005016 | 1.63 | null | Curative (C) | null | 2018-02-25 | Capecitabine | N | Y | 300025042 | CAPECITABINE |
| 300008273 | 300005053 | 1.66 | null | Palliative (P) | 2014-12-29 | 2015-12-09 | CARBOPLATIN + RT | 01 | null | 300025458 | CAPECITABINE |
| 300008274 | 300005057 | 1.67 | 102.5 | Palliative (P) | 2016-06-03 | 2016-10-22 | CARBOPLATIN | 2 | N | 300025465 | CAPECITABINE + OXALIPLATIN |